WEDNESDAY, Jan. 9, 2019 -- Ritalin, a widely used stimulant drug to treat attention-deficit/hyperactivity disorder (ADHD), likely poses no risk of heart damage in children, new research in monkeys suggests.
The findings are "very reassuring," said the study's principal investigator, Dr. Steven Lipshultz.
MONDAY, Dec. 10, 2018 -- Autism and attention-deficit/hyperactivity disorder (ADHD) are so closely linked that they not only run in families, but each increases the risk of the other in future siblings, a new study finds.
Younger siblings of children with autism have a 30-fold increased relative risk they'll be diagnosed with autism themselves. They're also nearly four times as likely to be diagnosed with ADHD, researchers reported.
MONDAY, Nov. 26, 2018 -- Millions of American kids with attention-deficit/hyperactivity disorder (ADHD) may have a genetic vulnerability to the disease, a new study suggests.
Researchers analyzed data from more than 55,000 individuals and identified 12 gene regions linked with ADHD. These regions probably affect the central nervous system, the study authors said. The discovery might help scientists develop new treatments for ADHD, which affects more than 9 percent of American children.